It develops when the cartilage that cushions the ends of the bones gradually wears down, allowing the bones to rub against each other
Although data from early phase trials suggest that retatrutide is well tolerated with a similar adverse event profile to GLP-1 RAs, additional research assessing long-term safety and efficacy of retatrutide in people living with obesity and/or T2D (including cardiovascular outcomes) is awaited over the next five years
Liu W, Zhou W, Zhao P, Wu T, Gu H, Li Y, Zhong C, Bai H, Zhao N, Huang X (2025) PD-Like pathogenesis in Caenorhabditis elegans intestinally infected with Nocardia farcinica and the underlying molecular mechanisms
Serious safety concerns have surrounded Melanotan-II since it was first developed at the University of Arizona in the 1990s
This makes it a valuable tool in clinical research for: Bulking Support: Helping athletes consume the high caloric intake necessary for growth